MABVAX THERAPEUTICS, INC.

Follow

Organization

San Diego, CA, US

Organizations

Please log in for detailed analytics

Patents Grantslast 30 patents

Information Patent Grant
Human monoclonal antibodies to ganglioside GD2
- Patent number 9,856,324
- Issue date Jan 2, 2018
- MABVAX THERAPEUTICS, INC.
- Wolfgang Scholz
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Nucleic acids encoding human antibodies to sialyl-lewisa
- Patent number 9,475,874
- Issue date Oct 25, 2016
- MABVAX THERAPEUTICS, INC.
- Ritsuko Sawada
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
HUMAN MONOCLONAL ANTIBODIES TO GANGLIOSIDE GD2
- Publication number 20180346597
- Publication date Dec 6, 2018
- MabVax Therapeutics, Inc.
- Wolfgang SCHOLZ
- G01 - MEASURING TESTING
Information Patent Application
NUCLEIC ACIDS ENCODING HUMAN ANTIBODIES TO SIALYL-LEWIS A
- Publication number 20170015756
- Publication date Jan 19, 2017
- MabVax Therapeutics, Inc.
- Ritsuko SAWADA
- G01 - MEASURING TESTING
Information Patent Application
HUMAN MONOCLONAL ANTIBODIES TO GANGLIOSIDE GD2
- Publication number 20150353645
- Publication date Dec 10, 2015
- MabVax Therapeutics, Inc.
- Wolfgang SCHOLZ
- G01 - MEASURING TESTING
Information Patent Application
Nucleic Acids Encoding Human Antibodies To Sialyl-Lewis A
- Publication number 20150056134
- Publication date Feb 26, 2015
- MabVax Therapeutics, Inc.
- Ritsuko SAWADA
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Trademarklast 30 trademarks

Information Trademark
87043574 - MABVAX
- Serial number 87043574
- Filing date May 19, 2016
- MabVax Therapeutics, Inc.
- 5 - Pharmaceutical and veterinary preparations